Status:
COMPLETED
Caffeine Disposition After Inhalation
Lead Sponsor:
University of Tennessee
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Healthy
Eligibility:
All Genders
21-45 years
Phase:
NA
Brief Summary
The purpose of this study is to determine how fast caffeine gets into your body with a product called Aeroshot™. Aeroshot™ is a lipstick sized device that you slide open and then put your mouth over t...
Eligibility Criteria
Inclusion
- healthy volunteer
- non-smoker
Exclusion
- Take chronic medication
- Co-existing diseases
- Platelet count less than 100,000/uL (per microliter)
- Acute or chronic psychiatric condition
- Consume more than 300 mg of caffeine per day
- Participated in another study within last 30 days or donated blood in last 6 weeks
Key Trial Info
Start Date :
July 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 20 2017
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT02184104
Start Date
July 1 2014
End Date
March 20 2017
Last Update
October 26 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Tennessee Health Science Center
Memphis, Tennessee, United States, 38163